ACTRN12617001130358
Recruiting
Phase 2
Pilot study evaluating the efficacy of subcutaneous ketamine for the treatment of depression in the elderly.
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- niversity of Otago
- Enrollment
- 24
- Status
- Recruiting
- Last Updated
- 7 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Treatment with daratumumab injections in moderate to severe ME/CFSMyalgic Encephalomyelitis/Chronic Fatigue SyndromeMedDRA version: 20.1Level: LLTClassification code 10028414Term: Myalgic encephalomyelitisSystem Organ Class: 100000004862Therapeutic area: Diseases [C] - Nervous System Diseases [C10]EUCTR2022-000281-18-NOHaukeland University Hospital, Dept. of Oncology and Medical Physics10
Active, not recruiting
Phase 1
Daratumumab in ME/CFSMyalgic Encephalomyelitis/Chronic Fatigue SyndromeMedDRA version: 26.1Level: LLTClassification code: 10028414Term: Myalgic encephalomyelitis Class: 10021881Therapeutic area: Diseases [C] - Immune System Diseases [C20]CTIS2024-512500-19-00Helse Bergen HF10
Completed
Not Applicable
To evaluate the efficacy and safety of subcutaneous and intravenous abatacept.Rheumatoid arthritisJPRN-UMIN000013440Osaka Medical College50
Not yet recruiting
Phase 2
ESAR-814 StudyRheumatoid arthritis with moderate activityArthritis, RheumatoidArthritisJoint DiseasesRheumatic DiseasesMusculoskeletal DiseasesConnective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System DiseasesRPCEC00000230Center for Genetic Engineering and Biotechnology (CIGB), in Havana196
Recruiting
Not Applicable
Evaluation of Efficacy and Safety of subcutaneous Remsima injection in Subjetcs with Active Ankylosing SpondylitisDiseases of the musculoskeletal system and connective tissueKCT0008747CHONNAM NATIONAL UNIVERSITY BITGOEUL HOSPITA60